Smart pain monitor may reduce opioid use in endometriosis surgery

NCT ID NCT06732050

Completed Symptom relief Sponsor: Prof Urs Zingg Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This completed study tested whether a special pain monitor (NOL index) could help doctors give the right amount of pain medication during laparoscopic endometriosis surgery. The goal was to reduce total painkiller use and improve recovery. The study included 125 premenopausal women undergoing surgery for endometriosis or adenomyosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nociception Level (NOL) index monitor
What this could lead to: If successful, this could help doctors give just the right amount of pain medication during surgery, reducing side effects and improving recovery for endometriosis patients.
What could go wrong: This is a small, completed study, so results may not apply to all patients. The device may not significantly reduce painkiller use or improve outcomes compared to standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOMYOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenomyosis endometriosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIOPERATIVE ANALGESIA IN ENDOMETRIOSIS

Contacts and locations

Locations

Spital Limmattal

Schlieren, Canton of Zurich, 8952, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.